Cargando…

Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012

INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a progressive and rapid course. Fatigue and depression are common among ALS patients. The aim of this study was to determine the relationship between depression and fatigue in Iranian ALS patients. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazemi, Maryam, Raad, Marjan Hassani, Arzoomanian, Christineh Serob, Ghasemzadeh, Azizreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Electronic physician 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844488/
https://www.ncbi.nlm.nih.gov/pubmed/27123230
http://dx.doi.org/10.19082/2194
_version_ 1782428781802160128
author Nazemi, Maryam
Raad, Marjan Hassani
Arzoomanian, Christineh Serob
Ghasemzadeh, Azizreza
author_facet Nazemi, Maryam
Raad, Marjan Hassani
Arzoomanian, Christineh Serob
Ghasemzadeh, Azizreza
author_sort Nazemi, Maryam
collection PubMed
description INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a progressive and rapid course. Fatigue and depression are common among ALS patients. The aim of this study was to determine the relationship between depression and fatigue in Iranian ALS patients. METHODS: In this 2012 cross-sectional study, 40 ALS patients, including 22 females and 18 males, were selected through consecutive relapsing-remitting, and 40 age- and gender-matched health controls (HCs) were recruited from Loghman Hakim Hospital in Tehran, Iran. The Persian version of the Fatigue Severity Scale (FSS-Per) questionnaire and depression substance of Hospital Anxiety and Depression Scale (HADS) were used to assess fatigue and depression. Data were analyzed using the Kolmogorov-Sminov Test, Levene’s test, Independent Samples t-test, and Pearson product-moment correlation coefficient. RESULTS: We identified a significant and positive relationship between fatigue and depression in patients with ALS (p=0.000). Furthermore, the scores of fatigue and depression in ALS patients were higher than in non-ALS patients. CONCLUSION: The results indicated that there was a relationship between fatigue and depression in ALS patients and that early intervention services can improve these symptoms. Further studies are suggested to investigate the direction of such relationship.
format Online
Article
Text
id pubmed-4844488
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Electronic physician
record_format MEDLINE/PubMed
spelling pubmed-48444882016-04-27 Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012 Nazemi, Maryam Raad, Marjan Hassani Arzoomanian, Christineh Serob Ghasemzadeh, Azizreza Electron Physician Original Article INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a progressive and rapid course. Fatigue and depression are common among ALS patients. The aim of this study was to determine the relationship between depression and fatigue in Iranian ALS patients. METHODS: In this 2012 cross-sectional study, 40 ALS patients, including 22 females and 18 males, were selected through consecutive relapsing-remitting, and 40 age- and gender-matched health controls (HCs) were recruited from Loghman Hakim Hospital in Tehran, Iran. The Persian version of the Fatigue Severity Scale (FSS-Per) questionnaire and depression substance of Hospital Anxiety and Depression Scale (HADS) were used to assess fatigue and depression. Data were analyzed using the Kolmogorov-Sminov Test, Levene’s test, Independent Samples t-test, and Pearson product-moment correlation coefficient. RESULTS: We identified a significant and positive relationship between fatigue and depression in patients with ALS (p=0.000). Furthermore, the scores of fatigue and depression in ALS patients were higher than in non-ALS patients. CONCLUSION: The results indicated that there was a relationship between fatigue and depression in ALS patients and that early intervention services can improve these symptoms. Further studies are suggested to investigate the direction of such relationship. Electronic physician 2016-03-25 /pmc/articles/PMC4844488/ /pubmed/27123230 http://dx.doi.org/10.19082/2194 Text en © 2016 The Authors This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Original Article
Nazemi, Maryam
Raad, Marjan Hassani
Arzoomanian, Christineh Serob
Ghasemzadeh, Azizreza
Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012
title Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012
title_full Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012
title_fullStr Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012
title_full_unstemmed Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012
title_short Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012
title_sort fatigue and depression in iranian amyotrophic lateral sclerosis patients in tehran in 2012
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844488/
https://www.ncbi.nlm.nih.gov/pubmed/27123230
http://dx.doi.org/10.19082/2194
work_keys_str_mv AT nazemimaryam fatigueanddepressioniniranianamyotrophiclateralsclerosispatientsintehranin2012
AT raadmarjanhassani fatigueanddepressioniniranianamyotrophiclateralsclerosispatientsintehranin2012
AT arzoomanianchristinehserob fatigueanddepressioniniranianamyotrophiclateralsclerosispatientsintehranin2012
AT ghasemzadehazizreza fatigueanddepressioniniranianamyotrophiclateralsclerosispatientsintehranin2012